Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients
- 1 November 1997
- journal article
- Published by Elsevier in Kidney International
- Vol. 52 (5) , 1390-1394
- https://doi.org/10.1038/ki.1997.466
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factorJournal of Cellular Physiology, 1996
- Evaluation of Red Blood Cell Lipoperoxidation in Hemodialysed Patients during Erythropoietin Therapy Supplemented or Not with IronNephron, 1995
- Heat-Aggregated IgA Prepared from Patients with IgA Nephropathy Increases Priming of Human Neutrophils to Produce Inositol Triphosphate following FMet-Leu-Phe Stimulation in vitroNephron, 1995
- Heat-Aggregated IgA Prepared from Patients with IgA Nephropathy Increases Calcium Mobilization and Superoxide Production of Human Neutrophils in vitroNephron, 1993
- Effects of Recombinant Human Erythropoietin and Correction of Anemia on Platelet Function in Hemodialysis PatientsNephron, 1991
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- Gamma interferon is able to enhance the oxidative metabolism of human neutrophilsBiochemical and Biophysical Research Communications, 1986
- Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificityKidney International, 1986
- Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophilsBiochemical and Biophysical Research Communications, 1983
- Anemia of the Regular Hemodialysis Patient and its TreatmentNephron, 1974